Seres Therapeutics Inc’s filing revealed that its Chief Legal Officer and EVP DesRosier Thomas unloaded Company’s shares for reported $475.0 on Nov 18 ’24. In the deal valued at $0.54 per share,878 shares were sold. As a result of this transaction, DesRosier Thomas now holds 135,192 shares worth roughly $0.13 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, von Moltke Lisa sold 977 shares, generating $528 in total proceeds. Upon selling the shares at $0.54, the insider now owns 32,415 shares.
Before that, Shaff Eric D. sold 2,505 shares. Seres Therapeutics Inc shares valued at $1,355 were divested by the CEO and President at a price of $0.54 per share. As a result of the transaction, Shaff Eric D. now holds 170,389 shares, worth roughly $0.16 million.
JP Morgan downgraded its Seres Therapeutics Inc [MCRB] rating to an Underweight from a a Neutral in a research note published recently. JP Morgan began covering MCRB with “Neutral” recommendation on April 21, 2023. Goldman revised its rating on July 23, 2021. It rated MCRB as “a Sell” which previously was an “a Neutral”.
Price Performance Review of MCRB
On Tuesday, Seres Therapeutics Inc [NASDAQ:MCRB] saw its stock jump 9.20% to $0.93. Over the last five days, the stock has gained 6.50%. Seres Therapeutics Inc shares have fallen nearly -33.30% since the year began. Nevertheless, the stocks have fallen -14.33% over the past one year. While a 52-week high of $2.05 was reached on 01/09/24, a 52-week low of $0.54 was recorded on 04/19/24. SMA at 50 days reached $0.7899, while 200 days put it at $0.8889.
Levels Of Support And Resistance For MCRB Stock
The 24-hour chart illustrates a support level at 0.8636, which if violated will result in even more drops to 0.7935. On the upside, there is a resistance level at 0.9733. A further resistance level may holdings at 1.0129. The Relative Strength Index (RSI) on the 14-day chart is 60.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0121, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 22.46%. Stochastics %K at 67.20% indicates the stock is a holding.
How much short interest is there in Seres Therapeutics Inc?
A steep rise in short interest was recorded in Seres Therapeutics Inc stocks on 2024-11-29, dropping by -0.47 million shares to a total of 17.38 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 17.85 million shares. There was a decline of -2.71%, which implies that there is a negative sentiment for the stock.
